Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26,263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
"Weighing the Pros and Cons of Everything": A Qualitative Descriptive Study Exploring Perspectives About Living Donor Kidney Transplantation From Parents of Chinese Canadian Pediatric Patients With Chronic Kidney Disease.
Pol SJ, Selkirk EK, Damer A, Mucsi I, Abbey S, Edwards B, Fung K, Gill J, Neves P, Ng SY, Parekh RS, Wright L, Wu M, Anthony SJ. Pol SJ, et al. Among authors: wu m. Can J Kidney Health Dis. 2024 May 10;11:20543581241249872. doi: 10.1177/20543581241249872. eCollection 2024. Can J Kidney Health Dis. 2024. PMID: 38737938 Free PMC article.
Chemoenzymatic Tagging of Tn/TF/STF Antigens in Living Systems.
Yang Y, Chen M, Wu M, Hong S, Gao B, Liu Y, Yu C, Young TS, Chapla DG, Yang JY, Cappiello JR, Li JP, Sharpless KB, Moremen KW, Wu P. Yang Y, et al. Among authors: wu m. Isr J Chem. 2023 Oct;63(10-11):e202300081. doi: 10.1002/ijch.202300081. Epub 2023 Sep 15. Isr J Chem. 2023. PMID: 38737670
TaSRT2 recognizes a viral protein to activate host immunity by increasing histone acetylation.
Zhong K, Jiang Y, Hu H, Yuan B, Wu M, Tu A, Xu G, Cai L, Liu T, Gao S, Li L, Liao Q, Guo L, Xia Y, Liu P, Cheng Y, Lin L, Zhang C, Chen J, Yang J. Zhong K, et al. Among authors: wu m. Sci Bull (Beijing). 2024 Apr 27:S2095-9273(24)00313-X. doi: 10.1016/j.scib.2024.04.064. Online ahead of print. Sci Bull (Beijing). 2024. PMID: 38735788 No abstract available.
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Goodyear CS, Patel A, Barnes E, Willicombe M, Siebert S, de Silva TI, Snowden JA, Lim SH, Bowden SJ, Billingham L, Richter A, Carroll M, Carr EJ, Beale R, Rea D, Parry H, Pirrie S, Lim Z, Satsangi J, Dunachie SJ, Cook G, Miller P, Basu N, Gilmour A, Hodgkins AM, Evans L, Hughes A, Longet S, Meacham G, Yong KL, A'Hearne MJ, Koh MBC, Burns SO, Orchard K, Paterson C, McIlroy G, Murray SM, Thomson T, Dimitriadis S, Goulston L, Miller S, Keillor V, Prendecki M, Thomas D, Kirkham A, McInnes IB, Kearns P; OCTAVE-DUO investigators. Goodyear CS, et al. Lancet Rheumatol. 2024 May 8:S2665-9913(24)00065-1. doi: 10.1016/S2665-9913(24)00065-1. Online ahead of print. Lancet Rheumatol. 2024. PMID: 38734019 Free article.
26,263 results
You have reached the last available page of results. Please see the User Guide for more information.